01 SANOFI CHIMIE Gentilly FR (1)
02 CLL Pharma Nice Cedex 3 FR (1)
03 EUROAPI ITALY S.R.L. Brindisi IT (1)
04 TOPFOND PHARMACEUTICAL CO., LTD. Zhumadian CN (1)
05 WUXI FORTUNE PHARMACEUTICAL CO., LTD. Wuxi CN (1)
01 Spiramycin (5)
01 China (2)
02 France (3)
01 Expired (1)
02 Valid (2)
03 Withdrawn by Holder (2)
84
PharmaCompass offers a list of Spiramycin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Spiramycin manufacturer or Spiramycin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Spiramycin manufacturer or Spiramycin supplier.
PharmaCompass also assists you with knowing the Spiramycin API Price utilized in the formulation of products. Spiramycin API Price is not always fixed or binding as the Spiramycin Price is obtained through a variety of data sources. The Spiramycin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1403-57-2 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1403-57-2, including repackagers and relabelers. The FDA regulates 1403-57-2 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1403-57-2 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 1403-57-2 supplier is an individual or a company that provides 1403-57-2 active pharmaceutical ingredient (API) or 1403-57-2 finished formulations upon request. The 1403-57-2 suppliers may include 1403-57-2 API manufacturers, exporters, distributors and traders.
click here to find a list of 1403-57-2 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 1403-57-2 CEP of the European Pharmacopoeia monograph is often referred to as a 1403-57-2 Certificate of Suitability (COS). The purpose of a 1403-57-2 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 1403-57-2 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 1403-57-2 to their clients by showing that a 1403-57-2 CEP has been issued for it. The manufacturer submits a 1403-57-2 CEP (COS) as part of the market authorization procedure, and it takes on the role of a 1403-57-2 CEP holder for the record. Additionally, the data presented in the 1403-57-2 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 1403-57-2 DMF.
A 1403-57-2 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 1403-57-2 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 1403-57-2 suppliers with CEP (COS) on PharmaCompass.
We have 4 companies offering 1403-57-2
Get in contact with the supplier of your choice: